Prime Medicine, Inc., a biotechnology company, delivers genetic therapies to address diseases by deploying gene editing technology. It offers Prime Editors with a Prime Editor protein, comprising a fusion between a Cas protein and a reverse transcriptase enzyme; and a pegRNA, which targets the Prime Editor to a specific genomic location and provides a template for making the desired edit to the target DNA sequence. The company was incorporated in 2019 and is headquartered in Cambridge, Massachusetts.

	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23
revenue		5.21M -		5.21M -
cost of revenue	2.76K -	2.98K 7.97%	4.86M 163,020.81%	12.01M 147.15%	4.65M 61.27%
gross profit	-2.76K -	5.21M 188,760.14%	-4.86M 193.35%	-6.80M 39.97%	-4.65M 31.61%
selling and marketing expenses	1.25M -				-4.65M -
general and administrative expenses	3.76K -	3.16M 84,085.30%	13.92M 340.35%	29.82M 114.16%	43.39M 45.50%
selling general and administrative expenses	1.25M -	3.16M 152.56%	13.92M 340.35%	29.82M 114.16%	38.73M 29.90%
research and development expenses	920K -	2.98M 223.91%	70.55M 2,267.45%	86.72M 22.93%	147.91M 70.54%
other expenses		-11.48M -	-80.99M 605.59%	1.90M 102.35%	13.50M 609.41%
cost and expenses	2.17M -	6.14M 182.78%	84.47M 1,275.35%	116.54M 37.96%	191.29M 64.14%
operating expenses	2.17M -	6.14M 182.78%	84.47M 1,275.35%	116.54M 37.96%	186.64M 60.14%
interest expense				12.13M -
ebitda	-2.17M -	-11.76M 441.25%	-83.52M 610.40%	-108.42M 29.82%	-186.64M 72.15%
operating income	-2.17M -	-932K 57.09%	-84.47M 8,963.73%	-116.54M 37.96%	-191.29M 64.14%
depreciation and amortization	6.52K -	-10.82M 166,214.18%	959K 108.86%	8.13M 747.55%	4.65M 42.75%
total other income expenses net	-353K -	-611K 73.09%	-81.38M 13,218.99%	-6.22M 92.35%	-7.12M 14.38%
income before tax	-2.52M -	-1.54M 38.89%	-165.85M 10,648.74%	-122.77M 25.98%	-198.41M 61.61%
income tax expense	4K -	1.87M 46,575%	-486K 126.03%	-948K 95.06%	-279K 70.57%
net income	-2.53M -	-3.41M 34.84%	-165.37M 4,749.47%	-121.82M 26.33%	-198.13M 62.64%
weighted average shs out	95.73M -	95.73M 0%	95.73M 0%	97.21M 1.55%	90.97M 6.42%
weighted average shs out dil	95.73M -	95.73M 0%	95.73M 0%	97.21M 1.55%	90.97M 6.42%
eps	-0.03 -	-0.04 34.85%	-1.73 4,759.55%	-1.25 27.75%	-2.18 74.40%
epsdiluted	-0.03 -	-0.04 34.85%	-1.73 4,759.55%	-1.25 27.75%	-2.18 74.40%

NASDAQ:PRME

Prime Medicine, Inc.

Last Close

4.31

30/08 20:00

Market Cap

666.17M

Beta: -

Volume Today

362.75K

Avg: 197.03K

PE Ratio

−3.44

PFCF: −3.82

Preview